Physician profile
David Lovejoy
NPI 1528328556
$84,845.23
in general payments reported to CMS, 2019-2025
19 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $472 · 2021: $946 · 2022: $7,804 · 2023: $6,280 · 2024: $26K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Consulting Fee: $23K · Travel and Lodging: $6,019 · Food and Beverage: $3,687 · Honoraria: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,461.50 |
| Consulting Fee | $23,446.60 |
| Travel and Lodging | $6,018.68 |
| Food and Beverage | $3,687.47 |
| Honoraria | $482.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50,965.28 | 2019-2025 | Axonics, Advantage System, General - Female Sui |
| Axonics, INC. | $30,268.74 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,396.24 | 2021-2025 | Altaviva, Interstim |
| Coloplast Corp | $900.59 | 2019-2021 | |
| Abbvie INC. | $358.02 | 2019-2025 | |
| Allergan, INC. | $180.81 | 2019-2022 | |
| Astellas Pharma US INC | $153.75 | 2021 | |
| Abc Home Medical Supply, INC. | $135.34 | 2022-2024 | |
| Femselect INC. | $107.30 | 2025 | Enplace |
| Caldera Medical, INC | $72.27 | 2022 | |
| Laborie Medical Technologies Corp. | $68.12 | 2025 | |
| Medtronic USA, INC. | $57.59 | 2019-2020 | |
| Urovant Sciences INC | $52.70 | 2022 | |
| Pfizer INC. | $27.56 | 2024 | |
| Hologic Sales and Service, LLC | $23.43 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $21.14 | 2019 | |
| Baxter Healthcare | $20.06 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $19.00 | 2020 | |
| Tesaro, INC. | $17.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lovejoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.